Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Yarrow Bioscience, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +8 vs. Q1 2025
- Shares held
- 8.10M
- +938.5K (+13.1%) vs. Q1 2025
- Total value
- $13.4M
- +$1.88M (+16.4%) vs. Q1 2025
- New holders
- 15
- 8 more added
- Sold out
- 7
- 12 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 11 | $18 | 0.00% | +11 | New |
| Farther Finance Advisors, LLC | 16 | $26 | 0.00% | +16 | New |
| Truvestments Capital LLC | 25 | $41 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 65 | $107 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 146 | $241 | 0.00% | −5,835−97.6% | Reduced |
| CWM, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| MB, Levis & Associates, LLC | 1,041 | $1.72K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,469 | $2.42K | 0.00% | −15,694−91.4% | Reduced |
| Royal Bank of Canada | 2,440 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,804 | $4.63K | 0.00% | −1,492−34.7% | Reduced |
| Morgan Stanley | 3,411 | $5.63K | 0.00% | −9,400−73.4% | Reduced |
| Corsair Capital Management, L.P. | 10,000 | $16.5K | 0.00% | +10,000 | New |
| Renaissance Technologies LLC | 10,543 | $17.4K | 0.00% | −104,600−90.8% | Reduced |
| Gsa Capital Partners LLP | 13,466 | $22.0K | 0.00% | +13,466 | New |
| State Street Corp | 15,765 | $26.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 18,298 | $30.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 22,418 | $36.0K | 0.00% | +22,418 | New |
| Raymond James Financial Inc | 22,164 | $36.6K | 0.00% | +22,164 | New |
| Northern Trust Corp | 23,110 | $38.1K | 0.00% | −861−3.6% | Reduced |
| Velan Capital Investment Management LP | 30,000 | $49.5K | 0.05% | +30,000 | New |
| HRT Financial LP | 42,037 | $69.0K | 0.00% | +15,795+60.2% | Added |
| BlackRock, Inc. | 44,405 | $73.3K | 0.00% | −38,174−46.2% | Reduced |
| Harvest Investment Services, LLC | 51,326 | $84.7K | 0.02% | +51,326 | New |
| Staley Capital Advisers Inc | 51,472 | $84.9K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 56,908 | $93.9K | 0.00% | +23,856+72.2% | Added |
| Susquehanna International Group, LLP | 57,814 | $95.4K | 0.00% | +52+0.1% | Added |
| Prelude Capital Management, LLC | 64,584 | $106.6K | 0.01% | −76,918−54.4% | Reduced |
| Bridgeway Capital Management, LLC | 76,958 | $127.0K | 0.00% | +25,000+48.1% | Added |
| Squarepoint Ops LLC | 78,474 | $129.5K | 0.00% | +78,474 | New |
| Boothbay Fund Management, LLC | 106,459 | $175.7K | 0.01% | +106,459 | New |
| Polygon Management Ltd. | 115,384 | $190.4K | 0.03% | +115,384 | New |
| Jane Street Group, LLC | 124,822 | $206.0K | 0.00% | +124,822 | New |
| Geode Capital Management, LLC | 133,329 | $220.0K | 0.00% | −161−0.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 161,951 | $267.2K | 0.00% | +76,973+90.6% | Added |
| Exome Asset Management LLC | 208,970 | $344.8K | 0.28% | −253,831−54.8% | Reduced |
| Ikarian Capital, LLC | 290,000 | $478.5K | 0.16% | +290,000 | New |
| Patient Square Capital LP | 317,033 | $523.1K | 0.19% | +60,000+23.3% | Added |
| Palo Alto Investors LP | 445,434 | $735.0K | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 496,297 | $818.9K | 0.00% | +20,647+4.3% | Added |
| Kennedy Capital Management, Inc. | 570,740 | $941.7K | 0.02% | +570,740 | New |
| DAFNA Capital Management LLC | 636,103 | $1.05M | 0.29% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 644,134 | $1.06M | 0.00% | +300,000+87.2% | Added |
| Acorn Capital Advisors, LLC | 736,572 | $1.22M | 0.79% | −49,366−6.3% | Reduced |
| Citadel Advisors LLC | 1,040,070 | $1.72M | 0.00% | −60,259−5.5% | Reduced |
| Cormorant Asset Management, LP | 1,370,938 | $2.26M | 0.17% | +1,370,938 | New |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −1,394,336−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −217,978−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −70,419−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −45,557−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,574−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −18,015−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,576−100.0% | Sold out |